Related Experiment Video

Updated: Jun 7, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.7K

Potential Anticancer Effects of Isoflavone Prunetin and Prunetin Glycoside on Apoptosis Mechanisms

Se Hyo Jeong1, Hun Hwan Kim1, Min Yeong Park1

  • 1Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.

International Journal of Molecular Sciences
|November 9, 2024
PubMed

Insights

Prunetin and its glycoside, prunetin glucoside, show potential as natural anticancer agents by inducing apoptosis (programmed cell death). This review explores their effects on cancer cell death pathways, offering a promising alternative to chemical treatments.

Area of Science:

  • * Molecular Biology
  • * Pharmacology
  • * Biochemistry

Background:

  • * Cancer arises from uncontrolled cell proliferation and differentiation.
  • * Apoptosis (programmed cell death) is a key mechanism for cancer control.
  • * Flavonoids, natural compounds from plants, exhibit anticancer properties with fewer side effects than conventional therapies.

Purpose of the Study:

  • * To review the anticancer potential of prunetin and its glycoside, prunetin glucoside.
  • * To investigate their mechanism of action via apoptosis induction.
  • * To explore their effects on cancer cell death signaling pathways.

Main Methods:

  • * Literature review of studies on prunetin, prunetin glucoside, and apoptosis.
  • * Analysis of research on the anticancer effects of these compounds in various cancer models.
  • * Examination of their impact on cell death signaling pathways.

Main Results:

  • * Prunetin and prunetin glucoside demonstrate significant anticancer effects.
  • * These effects are mediated through the induction of apoptosis.
  • * Both compounds show promise in targeting cancer cell death pathways.

Conclusions:

  • * Prunetin and prunetin glucoside are promising natural compounds for cancer therapy.
  • * Their ability to induce apoptosis offers a targeted approach to cancer treatment.
  • * Further research can enhance the therapeutic application of these flavonoids.
Keywords:
anticancerapoptosisisoflavoneprunetin glucosidessignaling pathway

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.2K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K